Drawing for RECIPHARM

USPTO serial 79089041

RECIPHARM

Reviewed by CopyMark Law Group

Reg. 4061976Status 706Registered
Filing date
Status date
Registration date
Nov 29, 2011
Examiner
MAKHDOOM, SAIMA
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with RECIPHARM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard J. McKenna

Richard J. McKenna FOLEY & LARDNER LLP3000 K Street, N.W. Suite 600Washington, DC 20007-5109UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical preparations, namely, antibacterial pharmaceuticals, anti-diabetic pharmaceuticals, balms for pharmaceutical purposes, cardiovascular pharmaceuticals, dermatological pharmaceutical products, digestives for pharmaceutical purposes, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders, ocular pharmaceuticals, pharmaceutical anti-allergic preparations and substances, pharmaceutical anti-allergic preparations and substances, anticoagulants, antidepressants, appetite suppressants, pharmaceutical preparations for use in chemotherapy, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations for the treatment of infectious diseases, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for wounds, pharmaceutical preparations for use in urology, pharmaceutical preparations for skin care, pharmaceutical preparations for the treatment of kidney diseases, pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders, and pharmaceutical preparations for the treatment of the thyroid gland ]SECTION 71 - CANCELLED—
042[ Medical research laboratory services; ] [ consultation services related to research in the field of development of surgical products; ] [ product development; development of medical products; and ] scientific and technological services and research and design relating thereto for medical purposes, namely, medical and scientific research in the fields of [ cancer treatment, cardiovascular treatment, treatment of infectious diseases, and ] treatment of a wide variety of major medical human disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 17, 2024INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Feb 7, 2024INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Feb 7, 2024INPCINVALIDATION PROCESSED—
Jan 31, 2024INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 31, 2023NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 31, 202371AGREGISTERED-SEC.71 ACCEPTED—
Apr 17, 2023EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Nov 2, 2022PR71POST REGISTRATION ACTION MAILED - SEC.71—
Oct 24, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 10, 2022ES71TEAS SECTION 71 RECEIVED—
Nov 29, 2020REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Nov 6, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 30, 2020RNWLINTERNATIONAL REGISTRATION RENEWED—
Oct 12, 2018INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Sep 5, 2018INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 5, 2018INPCINVALIDATION PROCESSED—
Aug 17, 2018INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 4, 2017NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Dec 4, 2017C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Dec 1, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 16, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 8, 2017ES75TEAS SECTION 71 & 15 RECEIVED—
Nov 29, 2016REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 10, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 23, 2012FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 23, 2012FIMPFINAL DISPOSITION PROCESSED—
Feb 29, 2012FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 29, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 20, 2011GPNXNOTIFICATION PROCESSED BY IB—
Sep 13, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 13, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 24, 2011OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 24, 2011OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 11, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 11, 2011ALIEASSIGNED TO LIE—
Jul 29, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 8, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 8, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 8, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 29, 2011RFNTREFUSAL PROCESSED BY IB—
Jan 11, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 11, 2011RFRRREFUSAL PROCESSED BY MPU—
Jan 10, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 9, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 31, 2010DOCKASSIGNED TO EXAMINER—
Nov 23, 2010MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 19, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 18, 2010REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance